Metabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Harrison, Douglas J.Chi, Yueh-YunTian, JingHingorani, PoojaMascarenhas, LeoMcCowage, Geoffrey B.Weigel, Brenda J.Venkatramani, RajkumarWolden, Suzanne L.Yock, Torunn I.Rodeberg, David A.Hayes-Jordan, Andrea A.Teot, Lisa A.Spunt, Sheri L.Meyer, William H.Hawkins, Douglas S.Shulki, Barry L.Parisi, Marguerite T.2022-06-272022-06-2720212045-7634http://hdl.handle.net/10342/10731enchemotherapymaximum standard uptake value (SUVmax)rhabdomyosarcomaMetabolic Response as Assessed by 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Does Not Predict Outcome in Patients with Intermediate- or High-Risk Rhabdomyosarcoma: A Report from the Children's Oncology Group Soft Tissue Sarcoma CommitteeArticle10.1002/cam4.3667